Bioventus launches Osteomatrix+ bone graft

Bioventus announced today that it has started selling Osteomatrix+ – a moldable bone graft substitute intended for a variety of orthopedic and spine bone remodeling applications. Bioventus officials boast that Osteomatrix+ has improved moldability, flexibility and versatility versus its predecessor. “Osteomatrix+ represents the first of several next-generation products that will be added to the Bioventus portfolio […]

Philips touts new gantry design for Azurion

Philips (NYSE:PHG) today touted the launch of its Azurion with FlexArm, which the company said enables physicians to more easily perform image-guided procedures. As the clinician moves the system, the image bean maintains alignment with the patient and provides consistent visualization, according to Philips. Azurion with FlexArm moves on eight axes, controlled by the Axsys controller. […]

Itamar Medical to raise $12m with private placement

Itamar Medical (TASE:ITMR) said today that it stands to raise nearly $12 million in a private placement with American and Israeli investors. Caesarea, Israel-based Itamar, which makes sleep apnea and heart failure diagnostic devices, said the round consists of $8 million raised from Deerfield Management, Triple Gate Capital, West Elk Partners, and Alpha Capital Anstalt. Another […]

Focusing on usability can limit medical device recalls: Here’s how

By Stephanie Van Ness and Rex Palmer of Boston UX Building great software has always been challenging. Building software that safeguards patients while flawlessly controlling sensitive embedded and connected medical devices — from room-sized proton radiation systems to portable automatic external defibrillators (AED) — magnifies the challenge. It should be no surprise that design issues cause many device recalls. So […]

Sandoz launches PFS alternative to epinephrine auto-injector

Novartis (NYSE:NVS) division Sandoz said today that it launched its Symjepi epinephrine pre-filled syringe in the U.S. The company’s product is designed as an alternative to epinephrine auto-injectors to treat emergency allergic reactions. Get the full story at our sister site, Drug Delivery Business News. The post Sandoz launches PFS alternative to epinephrine auto-injector appeared first on MassDevice.

European scientists develop absorbable bandages

Study co-author Elizaveta Permyakova of Russia’s National University of Science and Technology worked on developing the absorbable bandage. An international research group has developed a biocompatible bandage material that has antibacterial properties and will not require changing, a potential boon for burn patients. The material is self-absorbable, and a new bandage can be put directly […]

Stimwave touts 6 month MIS SCS trial results

Stimwave today touted six-month data from a trial of its minimally invasive spinal cord stimulator system. The company’s pivotal Surf trial compared a variety of waveform options without the need for separate trial devices. Stimwave reported that in the high and low frequency groups, back and leg pain responders were more than 92% and 86%, […]

Medtronic kicks off study for pain pump

Medtronic (NYSE:MDT) said today that it enrolled the first patient in a study to assess the use of its SynchroMed II intrathecal drug delivery system as an alternative to oral opioids. The 100-patient Embrace TDD study is slated to follow patients who have weaned off all oral opioids, in the hopes of positioning the SynchroMed II […]

Cala Health launches trial for Cala Two neurostim device for essential tremor

Cala Health last month launched a clinical trial of the latest version of its wearable neurostimulator for treating essential tremor, eyeing extended use of the wrist-worn device. The Burlingame, Calif.-based company won de novo clearance from the FDA last April for the Cala One device for transient relief in adults with essential tremor. The 500-patient, single-arm […]

Proteus debuts digital cancer drug

Proteus Digital Health said today that the first cancer patients were treated using its digital oncology therapy, which combines oral chemotherapy with an ingestible sensor. Patients with stage 3 and 4 colorectal cancer at the University of Minnesota Health and Fairview Health Services were treated with digital capecitabine. The Redwood City, Calif.-based company plans to use […]